Novartis Expects Annual Cost Synergies of $350 Million From Alcon Integration

13.09.2011 - Novartis Tuesday said it now expects the integration of Alcon as an eye care segment to create annual cost synergies of $350 million by 2013. In January 2010, on acquiring a 77%...